<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02380495</url>
  </required_header>
  <id_info>
    <org_study_id>Verbale n°13/2013</org_study_id>
    <nct_id>NCT02380495</nct_id>
  </id_info>
  <brief_title>&quot;Studio NaVA&quot; - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma</brief_title>
  <official_title>Studio NaVA - Studio Nazionale Sulla Qualità Della Vita in Adolescenti Con Rinite Allergica Con e Senza Asma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stefania La Grutta, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Studio Nava&quot; is a National Study aiming to assess allergic rhinitis and asthma outcomes on
      Quality of Life and Quality of Sleep in adolescent patients by means of Web Survey. &quot;Studio
      Nava&quot; also proposes the innovative use of a web platform (&quot;http://nava.ibim.cnr.it/&quot;) that
      contains all standardized tools (medical-healthcare web form, ACT, Asthma control test; PSQI,
      Pittsburgh Sleep Quality Index; T5SS, Total Symptom Score; modified SIDRIA for adolescents;
      Rhinasthma; VAS scale), that will be available for the doctors after the registration to the
      web platform. Downloaded questionnaires will be delivered to case-patient, asking him/her to
      fill them during the waiting time of the visit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of the allergic rhinitis impact on quality of life</measure>
    <time_frame>2 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The impact of AR and asthma on quality of sleep</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1200</enrollment>
  <condition>Allergic Rhinitis</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Allergic rhinitis with/without asthma, from 14 to 17 years age</arm_group_label>
    <description>600 adolescents with allergic rhinitis with/without asthma, from 14 to 17 years age, recruited from Pediatricians of the Italian territory.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Without respiratory pathology</arm_group_label>
    <description>600 subject (5 for each participant Pediatrician) of the same age range, without respiratory pathology (patient family)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data Collection</intervention_name>
    <arm_group_label>Allergic rhinitis with/without asthma, from 14 to 17 years age</arm_group_label>
    <arm_group_label>Without respiratory pathology</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  600 adolescents with allergic rhinitis with/without asthma, from 14 to 17 years age,
             recruited from Pediatricians of the Italian territory

          -  600 subject (5 for each participant Pediatrician) of the same age range, without
             respiratory pathology (patient family)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical cases n°: 600 adolescents affected by allergic rhinitis with/without asthma,
             from 14 to 17 years age.

          -  Controls n°: 600 subject (5 for each participant Pediatrician) of the same age range,
             without respiratory pathology.

        Exclusion Criteria:

          -  Subjects that have not allergic rhinitis with/without asthma diagnosis or are &lt;14
             years old or &gt;17 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council</name>
      <address>
        <city>Palermo</city>
        <state>Sicily</state>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Biomedicine and Molecular Immunology, IBIM</name>
      <address>
        <city>Palermo</city>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</investigator_affiliation>
    <investigator_full_name>Stefania La Grutta, MD</investigator_full_name>
    <investigator_title>MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.</investigator_title>
  </responsible_party>
  <keyword>Adolescents</keyword>
  <keyword>Respiratory Pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

